Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886
about
Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infectionUnexploited Antineoplastic Effects of Commercially Available Anti-Diabetic DrugsEffects of the environmental contaminants DEHP and TCDD on estradiol synthesis and aryl hydrocarbon receptor and peroxisome proliferator-activated receptor signalling in the human granulosa cell line KGN.A20 protects mice from lethal liver ischemia/reperfusion injury by increasing peroxisome proliferator-activated receptor-alpha expressionAMPK enhances the expression of pancreatic duodenal homeobox-1 via PPARalpha, but not PPARgamma, in rat insulinoma cell line INS-1Peroxisome proliferator-activated receptors (PPARs)-independent functions of fish oil on glucose and lipid metabolism in diet-induced obese mice.Polyunsaturated fatty acids and modulation of cholesterol homeostasis in THP-1 macrophage-derived foam cells.Fatty acid oxidation and signaling in apoptosis.Suppression of cardiac myocyte hypertrophy by conjugated linoleic acid: role of peroxisome proliferator-activated receptors alpha and gamma.Inhibition of hepatic glycogen synthesis by hyperhomocysteinemia mediated by TRB3Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells.Leukotriene B4 mediates inflammation via TRPV1 in duct obstruction-induced pancreatitis in rats.Down-regulation of vinculin upon MK886-induced apoptosis in LN18 glioblastoma cellsAcinar Cell Production of Leukotriene B4 Contributes to Development of Neurogenic Pancreatitis in MiceA pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysmEffects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors.Peroxisome proliferator-activated receptorα agonists differentially regulate inhibitor of DNA binding expression in rodents and human cells.The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathyThe fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation.Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?Leukotriene biosynthesis inhibitor MK886 impedes DNA polymerase activity.PPAR Agonists: I. Role of Receptor Subunits in Alcohol Consumption in Male and Female Mice.Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator-activated receptor α.5-lipoxygenase-activating protein as a modulator of olanzapine-induced lipid accumulation in adipocyteNAMPT knockdown attenuates atherosclerosis and promotes reverse cholesterol transport in ApoE KO mice with high-fat-induced insulin resistance.FADD is a key regulator of lipid metabolismFatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors.Interactions of PPAR-alpha and adenosine receptors in hypoxia-induced angiogenesis.Caloric Restriction Is More Efficient than Physical Exercise to Protect from Cisplatin Nephrotoxicity via PPAR-Alpha ActivationBlocking the peroxisome proliferator-activated receptor (PPAR): an overview.Fenofibrate subcellular distribution as a rationale for the intracranial delivery through biodegradable carrier.Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes.Regulation of liver fatty acid binding protein expression by clofibrate in hepatoma cells.Modulation peroxisome proliferators activated receptor alpha (PPAR alpha) and acyl coenzyme A: cholesterol acyltransferase1 (ACAT1) gene expression by fatty acids in foam cell.Involvement of PPARalpha in the growth inhibitory effect of arachidonic acid on breast cancer cells.Uncoupling protein-2 up-regulation and enhanced cyanide toxicity are mediated by PPARalpha activation and oxidative stress.Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids.MK886 inhibits the pioglitazone-induced anti-invasion of MDA-MB-231 cells is associated with PPARα/γ, FGF4 and 5LOX.Fenofibrate Induces Ketone Body Production in Melanoma and Glioblastoma Cells.
P2860
Q24646403-05C6B95E-D4B6-4325-83AD-235BE5D8FC7FQ26750845-F0F42478-4692-49C6-AB3E-5E384E0923C7Q30317260-BA1E31EF-E8F9-4FDE-B0D6-7D19C9AD330CQ33514016-FFA60F02-5F15-45C4-8A8B-D4D514FA5E08Q33557858-7E66429C-F969-4BE8-8AA7-10BAB3AB79A5Q34174646-D218C912-6121-49DF-86BD-CB6285F557EDQ34396151-226EC705-FBC7-4A46-BDC5-25635050D29CQ34658888-F492DA81-C22D-4AE3-A4D7-9CED60639577Q34751805-DCB23D76-0146-481E-BDC1-DCCB8547F728Q34805515-5FA524A9-B57D-4A2C-BE0D-48771CE880ECQ35044973-6EE485B2-4C92-49C1-8761-3318E1301899Q35048234-DFB1243D-54A2-4D08-9DD2-8CDDAE882D5EQ35061682-84ACC820-8084-4EA8-A608-06F02110346DQ35119979-8AD06C80-B675-4E76-BA07-C8511F7B076FQ35195538-58624AD1-00F2-45F3-A7BC-39D9E4661B4DQ35196626-9221A3F7-FB8D-4F27-B0F3-EE332C62338AQ36026632-2818CB35-2DA0-49D7-AA06-E05459B6A6EAQ36094329-6108B399-CF04-43E9-9755-7317B5198191Q36176531-2EFA92D6-F77D-4B7C-A8B3-0B41F965B97FQ36315284-C1373C6E-3499-40E1-B66F-3B26D5BE7037Q36591722-7219FB14-9B52-4E76-9EB0-E19B5E78A8C3Q36626061-8956C9AF-9F0B-42B0-A38B-EE6E398A53B4Q36642430-F8CC152C-0799-4B63-8F03-9C4D420F43F2Q36675315-0F5F6CB7-0566-4ECF-9477-46451E7DEFD1Q36916158-7D332314-94A5-40C4-AF32-76CFFD1032ABQ36941601-6BCDAFAE-8703-4DB1-AACC-C59A5E7833FEQ37141375-CAE487AC-DC99-4EB4-898C-78B9F3AC3D74Q37194497-3389E889-7E1E-4CA5-B3B1-21933F07D6E9Q37421898-C5163A33-C9B5-4D3A-9886-F8E2131D6320Q37675476-D68E35F7-2E7D-4606-A6D0-8C33C55F9E21Q38128537-980A300C-3C4B-4F50-A9C4-132F749EB26DQ38883374-643D7CBF-7366-4E08-A0F1-40A7D869B759Q39101221-80E8842C-3AF7-4BC7-9CB3-15F494C1E1E5Q39628443-8911EA6C-685C-4654-850A-0F0D9EBEE352Q39804569-3107E2FE-35B0-4782-98B3-6684DDCD9604Q40008527-492E4342-CA2B-4EBB-AB8C-535A093D9294Q40119125-FD7DDE86-ED48-4A0C-BD4F-9982E0CD0205Q40425308-A44E9B3A-1891-4E62-A3AF-156720570EAEQ41639652-C9C4A4B0-24FB-4D2E-B78C-5E5EFC36B9D3Q41851340-055EF8C3-6D7D-4872-8301-59D63D9F61AE
P2860
Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886
@ast
Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886
@en
Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886
@nl
type
label
Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886
@ast
Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886
@en
Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886
@nl
prefLabel
Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886
@ast
Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886
@en
Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886
@nl
P2093
P2860
P3181
P1433
P1476
Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886
@en
P2093
J P Kehrer
J P Vanden Heuvel
P Thuillier
S M Fischer
S S Biswal
P2860
P304
P3181
P356
10.1042/0264-6021:3560899
P407
P577
2001-06-15T00:00:00Z